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Abstract
An approach to estimate the influence of the treatment-type controls on the basic
reproduction number, R0, is proposed and elaborated. The presented approach allows
one to estimate the effect of a given treatment strategy or to compare a number of
different treatment strategies on the basic reproduction number. All our results are valid
for sufficiently small values of the control. However, in many cases it is possible to extend
this analysis to larger values of the control as was illustrated by examples.
Keywords: Disease control, Basic reproduction number, Treatment, Compartmental
epidemic model, Next generation matrix
1. Introduction
The basic reproduction number (R0), i.e. the number of infections generated by an
infected person in a fully susceptible population, is a key determinant of the dynamics
of an infectious disease. Interpretation of R0 is complex and is covered in a number of
excellent papers, see, e.g., [28, 15, 17] as well as the books [11, 10]. For the purposes of
this paper, we note that R0 can be interpreted as a threshold parameter: if R0 < 1 then
the disease can not sustain itself in the population and will eventually die out. That is, if
our goal is to push a disease towards extinction, then we can categorize a population-level
intervention as ‘effective’ if it reduces R0 from where it was before the intervention was
enacted.
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Computation of R0. R0 can be computed or estimated from partially empirical consider-
ations, for instance the “survival function”-based approach [16] that assumes knowledge
of both the survival probability F (t) and the infectivity b(t) of an individual as functions
of time. In addition to being difficult to implement, such approaches can hardly be used
for computing R0 in the case where there are more than one group of infected. This issue
was addressed in [12], where an elegant approach to computing R0 was proposed, termed
the next generation matrix (NGM) method. This method boils down to computing R0
as the spectral radius of a specially constructed matrix. Later, this method was detailed
and substantiated in a number of papers, see, e.g., [28] and [8]. The power of the NGM
approach lies in its universality. It can be applied to any population balance model as
long as it satisfies a number of very natural assumptions. The result is based on certain
properties of positive and inverse positive matrices, in particular M-matrices [3, 19].
Contribution. We aim at developing this approach in that we extend the notion of the
basic reproduction number to a class of controlled disease propagation models. Much of
applied theoretical epidemiology focuses on how treatment policies, intervention designs,
and novel treatments will impact the burden of a given disease by considering alternative
scenarios. There have been a large number of papers aimed at evaluating the efficacy of
different treatment schemes using various methods, from numerical simulation to optimal
control. We mention [7, 6, 21, 4, 2, 26, 23, 27, 14] for a short list of related research. Mod-
eling efforts have even attempted to measure the effects of control programs in historical
epidemics [5]. However, most modeling efforts do not attempt to measure intervention
effects systematically, i.e. by considering the joint effects of model parameters on the
relative efficacy of alternative interventions. In this paper we address treatment pro-
grams, i.e., the intervention strategies that result in moving infected individuals either
into a different group of infected (with different biological or behavioral characteristics)
or into a group of not-infected, which can correspond to susceptible, recovered or any
other group that consists of not contagious individuals.
When applied to one or several groups of infected individuals, the action of a treat-
ment strategy can be described by a parameter u that corresponds to a fraction of po-
tentially eligible individuals that are administered the treatment during a unit of time.
Typically, this fraction is rather small. Our first result consists in defining the notion of
a controlled reproduction number R0(u) which explicitly contains u as a parameter. The
next result allows to estimate the action of the particular treatment strategy on the value
of the controlled reproduction number R0(u). We formulate conditions under which the
application of a treatment strategy leads to the reduction in R0(u). This allows for eval-
uating the efficacy of a devised treatment strategy as well as for comparing the efficacy
of different strategies. The obtained results are illustrated by a number of examples.
The paper is organized as follows: Section 2 describes a general compartmental epi-
demic model and briefly introduces the NGM method for computing the basic repro-
duction number R0. The main result of the paper along with a discussion on further
extensions and ramifications of the developed approach are presented in Sec. 3. The
obtained results are illustrated by a number of examples in Sec. 4. The paper is con-
cluded with a discussion section. Finally, there are two appendices containing necessary
technical information.
2
2. Epidemics dynamics
2.1. A disease propagation model
When modeling the process of disease propagation in a heterogeneous population,
the standard procedure consists in dividing the total population into a number of classes
(compartments) according to some criteria relevant to the disease transmission: disease
status, ability to contract disease, behavioral (contact) pattern and so on. All individuals
within a compartment are assumed to be identical in their evolution. Thus we can
consider only the number of individuals within each compartment, denoted by xi, where
i = 1, . . . , n is the number of the compartment.
General formulation. The dynamics of these groups include transitions between groups
and the in- and outflows associated with these groups. In the following it is assumed that
the total inflow is constant over time and does not depend on the population size while
the outflow depends on both the size and the structure of the population. The evolution
of the ith state is thus described by the following compartmental DE:
x˙i = Φi(x) = wi +
∑
i 6=j
(
aij(x)− aji(x)
)− aixi, (1)
where x ∈ Rn≥0 is the state, wi is the constant inflow, aixi is the outflow from the i-th
compartment, and aij(x), i 6= j, is the flow rate from the j-th to the i-th compartment.
The flow rate functions are assumed to be C∞ for all x ∈ Rn≥0. Furthermore, all flow
rates have to satisfy the following properties:
wi ≥ 0, ai ≥ 0, aji(x) ≥ 0, ∀x ∈ Rn≥0, i, j = 1, . . . , n. (2a)
xi = 0 =⇒ aji(x) = 0 ∀i, j = 1, . . . , n. (2b)
The property (2b) implies that there is no outflow from an empty compartment.
Compartmental epidemic model. All state variables are divided into two groups depend-
ing on whether the respective compartment corresponds to the infectious individuals
(that is those able to transmit infection) or to the non-infectious individuals (regardless
of whether they were infected earlier or not).
Let there be l state variables representing the “infectious” compartments. We re-
arrange the states in the way that the vector of the state variables takes the form
x> = [x>I , x
>
N ], where x
>
I = [x1, . . . , xl] and x
>
N = [xl+1, . . . , xn] are the states associated
with “infectious” and “non-infectious” compartments. We will refer to the respective
compartments as the I- and N -compartments. Further, we write Φ(x) as the sum of two
vector-valued functions
Φ(x) = ΦI(x) +
[
w + Φin(x)− Φout(x)] = ΦI(x) + ΦC(x), (3)
3
where Φouti (x) =
∑
j 6=i
aji(x) + aixi, and
ΦI(x) =

( ∑
j>l
aij(x)
)
i=1,...,l
0
 , Φin(x) =

( ∑
j≤l
j 6=i
aij(x)
)
i=1,...,l( ∑
j 6=i
aij(x)
)
i=l+1,...,n
 .
Here, ΦIi is the rate at which new infections occur in the i-th compartment (new infection
means that the flow is to be from an N -compartment), Φin(x) is the vector of inter-
compartmental inflow rates not related to new infections, and Φout(x) are the outflow
rates from the respective compartments. Thus, ΦC(x) represents the totality of all flows
not related to new infections. Note that ΦIi (x) = 0 for all i > l as there is no inflow of
infected into the N -compartments.
The components of the respective vectors Φ(·)(x) satisfy the following properties (note
that (4a) and (4b) can be derived from (2)):
ΦIi (x),Φ
in
i (x),Φ
out
i (x) ≥ 0, ∀i = 1, . . . , n (4a)
{xi = 0} =⇒ {Φouti (x) = 0}, ∀i = 1, . . . , n (4b)
{xI = 0} =⇒ {ΦIi (x) = 0,Φini (x) = 0}, ∀i = 1, . . . , l. (4c)
The latter property implies that no new infections occur in a totally healthy population.
Assumptions. We conclude this section by making a number of epidemiologically moti-
vated assumptions.
A1. There is no steady inflow into the I-compartments, i.e., wi = 0, i = 1, . . . , l.
A2. There exists a positive constant µ such that ai ≥ µ > 0 for all i = 1, . . . , n. We
refer to µ as the baseline mortality rate.
2.2. Stability of a disease-free equilibrium
Let XDF ⊂ Rn≥0 be the set of disease-free states, i.e., XDF = {x ∈ Rn≥0|xi = 0, i =
1, . . . , l}.
Definition 2.1. Let x∗ be an equilibrium state, i.e., Φ(x∗) = 0. Then x∗ is said to be a
disease-free equilibrium (DFE) if x∗ ∈ XDF . Otherwise, x∗ is referred to as an endemic
infection equilibrium.
The system (1) is locally stable at a DFE x∗ if the linearized model ˙˜x = Ax˜ is
asymptotically stable. The latter holds if the spectrum of the structure matrix A contains
only the eigenvalues with negative real part, [9]. Such matrices are said to be Hurwitz.
Lemma 2.1 ([28]). Let x∗ be a DFE. The Jacobian matrices AI = DΦI(x)
∣∣
x=x∗ and
AC = DΦC(x)
∣∣
x=x∗ have the following form:
AI =
AI11 0
0 0
 , AC =
AC11 0
AC21 A
C
22
 ,
4
where AI11 is an [l × l] matrix with non-negative elements, AI11  0 and AC11 is an [l × l]
matrix with non-positive diagonal elements and non-negative off-diagonal elements1.
At this point, we make one more assumption regarding the behavior of the system in
the absence of the infection.
A3. AC is Hurwitz.
This assumption effectively implies that the DFE is asymptotically stable provided the
virus or whatever source of the infection has lost its contagiousness hence, no new infec-
tions occur.
Since the block matrix AC22 is stable at a DFE, stability of the whole system is
determined by the sum AI11 +A
C
11. Following the common convention we write F = A
I
11
and V = −AC11. Hence, the stability of a DFE is determined by the stability of the
matrix F − V .
Theorem 2.2 ([28]). The matrix F − V is Hurwitz if and only if ρ(FV −1) < 1.
We conclude this section with the following two definitions:
Definition 2.2. The matrix FV −1 is called the the next generation matrix.
Definition 2.3. The parameter R0 = ρ(FV
−1) is called the basic reproduction number.
In Def. 2.3, ρ(·) denotes the spectral radius of a matrix.
3. Evaluating the Effect of a Treatment-type Control
3.1. A controlled disease propagation model
We wish to model the effect of treatment-type controls, i.e., the controls that result in
moving individuals from the infected compartments to other (both infected and healthy)
compartments. In doing so, we restrict our attention to the cases where the control action
enters the equations linearly. In particular, this implies that there is no interference
between different treatment strategies, i.e., the rate at which people are administered to
treatment i does not depend on the respective rate associated with treatment j for all
pairs of i and j.
With the above assumptions in mind, we write the controlled population balance
model in the following form:
x˙ = Φ(x) + Φu(x)u, (5)
where u ∈ Rm≥0 is the vector of non-negative controls and the components of the control
matrix Φu(x) = [Φuik(x)], i = 1, . . . , n, k = 1, . . . ,m, have the following structure:
Φu·,k(x) =

∑
j≤l
j 6=i
auij,k(x)−
∑
j 6=i
auji,k(x)

i=1,...,l(∑
j≤l
auij,k(x)
)
i=l+1,...,n
 .
1See Appendix B for the explanation of the used notation.
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The control matrix describes the controlled flows from the infected compartments to both
infected and healthy compartments. This may correspond to isolating infected individ-
uals (corresponds to a transition from an I-compartment to another I-compartment) or
treating an infected individual (a flow from an I-compartment to an N -compartment).
The respective controlled flow rates auij,k(x) satisfy the conditions similar to those for
the flow rates of the original (uncontrolled) model:
auji,k(x) ≥ 0, ∀x ∈ Rn≥0, i, j = 1, . . . , n, i 6= j, k = 1, . . . ,m. (6a)
{xi = 0} =⇒ {auji,k(x) = 0} ∀i, j = 1, . . . , n, k = 1, . . . ,m. (6b)
Controllability. Note that at a DFE x∗, the control matrix vanishes identically as there
are no outflows from I-compartments: Φu(x∗) = 0[n×m]. This implies that at a DFE x∗,
the linearized model is effectively uncontrollable. Thus, one cannot use the linearized
model to design a feedback control law stabilizing the DFE.
3.2. Analysis of the controlled system
Due to the difficulties outlined above, we consider a somewhat simpler, but even more
practically relevant situation. Namely, we wish to study the system’s dynamics when a
constant control u∗ ∈ Rm≥0 is applied. We first formulate the result that extends Lemma
2.1 to include the controls u.
Lemma 3.1. Let u(t) = u∗ ∈ Rm≥0 for all t ≥ 0. The linearized model of (5) at a DFE
x∗ has the form
x˙ =
(
AI +AC +
m∑
k=1
Bku
∗
k
)
x, (7)
where AI and AC are defined in Lemma 2.1 and Bk, k = 1, . . . ,m are
Bk =
DΦu·,k(x)
Dx
∣∣∣∣
x=x∗
=
[
B11,k 0
B21,k 0
]
.
The matrices B11,k have non-positive diagonal and non-negative off-diagonal elements.
Furthermore, B11,k are weakly column diagonally dominant.
Proof. See Appendix A.
For the sake of notational simplicity and to comply with the previously accepted
notation, we will write Wi = −B11,i. Matrices Wi belong to the class of Z-matrices (see
Appendix B for details). However, these are not M-matrices as matrices Wi are typically
rank-deficient and hence non-invertible.
We are interested in the stability of the linearized system (7). As in the uncontrolled
case, the structure matrix of (7) is a block-lower triangular matrix, whose eigenvalues
coincide with the eigenvalues of the diagonal blocks. The lower right block is Hurwitz
according to A3. Thus, the stability of (7) is determined by the eigenvalues of the matrix
Ju = F − V −
m∑
k=1
Wkuk.
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The following lemma gives an important result that will be used in the sequel.
Lemma 3.2. Let V be a strictly column diagonally dominant Z-matrix with positive
diagonal elements. Then for any u ∈ Rm≥0 the matrix V +
∑m
k=1Wkuk is an M-matrix.
Proof. According to Lemma 3.1, matrices Wi = −B11,i have positive diagonal elements
and are weakly (non-strictly) column diagonally dominant. Thus for any positive u the
matrix V +
∑m
k=1Wkuk is a Z-matrix and is strictly column diagonally dominant. Then
it follows from Theorem 5.2 that V +
∑m
k=1Wkuk is a non-singular M-matrix.
Now we are ready to formulate a generalized version of Theorem 2.2
Theorem 3.3. The matrix F − V −∑mk=1Wkuk is Hurwitz if and only if
ρ
F (V + m∑
k=1
Wkuk
)−1 < 1.
We thus define the controlled reproduction number R0(u) as the spectral radius of
the perturbed matrix Q(u) = F (V +
∑m
k=1Wkuk)
−1
:
R0(u) = ρ
F (V + m∑
k=1
Wkuk
)−1 . (8)
Obviously, we have R0(0) = R0.
Let the uncontrollable system be such that R0 > 1. Theorem 3.3 allows for deter-
mining if a given constant control u∗ suffices to shift the value of the basic reproduction
number in order to make it less than 1. However, in many cases it is difficult to compute
the perturbed reproduction number R0(u). Thus, we would like to have a result that
would tell us if a given structure of the treatment allows for achieving the stated goal.
The following result provides the required estimation. We first consider the case
m = 1, i.e., we assume that there is a scalar control u > 0.
Theorem 3.4. Let R0, x0 and y0 be the spectral radius of FV
−1 as well as the right and
the left eigenvectors of FV −1 corresponding to R0, respectively. Let, furthermore, there
be only one eigenvalue of FV −1 coinciding with R0 and other eigenvalues be strictly less
than R0 in absolute value. For sufficiently small u, the sign of variation R0(u) − R0 is
determined by the sign of
R1 = −y>0 V −1Wx0R0/(y>0 x0) (9)
Proof. The eigenvalues of Q(u) = F (V +Wu)
−1
change continuously with u. Hence, we
can write the spectral radius R0(u) = R0 + uR1 +O(u
2) and the respective eigenvector
as x(u) = x0 + ux1 +O(u
2). We thus have
F (V + uW )−1(x0 + ux1 +O(u2)) = (R0 + uR1 +O(u2))(x0 + ux1 +O(u2)). (10)
First, we note that ddu (V + uW )
−1 = −(V + uW )−1W (V + uW )−1 and at u = 0 we
have ddu (V + uW )
−1
∣∣∣∣
u=0
= −V −1WV −1. Differentiating the left and the right sides of
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(10) and setting u = 0 we get:
(FV −1 −R0I)x1 = (FV −1WV −1 +R1I)x0. (11)
The matrix (FV −1−R0I) has a zero eigenvalue and the respective left eigenvector is y0,
i.e., y>0 (FV
−1−R0I) = 0. Multiplying both sides of (11) with y>0 and expressing R1 we
get:
R1 = −y>0 WV −1x0R0/(y>0 x0).
Finally, we note that for sufficiently small (and positive) u the sign of the difference
R0(u)−R0 is determined by the sign of R1, whence the result follows.
That is to say, we can determine if a given treatment is efficient (at least for small
values of u) by checking the sign of R1. If this sign is negative then by increasing u we
decrease R0(u) and eventually ensure that it becomes less than 1. Otherwise (if R1 > 0)
we conclude that the treatment program is inadequately formulated and does not lead
to a decrease in the reproduction number. See Sec. 4 for examples.
Following the same procedure, one can write R0(u) for the case when u ∈ Rm. We
have
R0(u
∗) = R0 +
m∑
k=1
u∗kR
k
1 +O(‖u∗‖2).
If the components of u∗ are sufficiently small, the contribution of each individual com-
ponent is determined by the respective term Rk1 , which is defined as
Rk1 = −y>0 WkV −1x0R0/(y>0 x0). (12)
We immediately arrive at the following result.
Theorem 3.5. For sufficiently small values of the controls ui, the effect of each control
is independent from the values of the remaining controls. The total change of R0(u) is
equal to the sum of individual contributions up to the high order term: R0(u) − R0 =∑m
k=1 ukR
k
1 +O(‖u‖2).
This result indicates the second potential use of R1. Let there be m treatment
strategies that aim at decreasing the value of R0(u). Then the most efficient strategy is
the one with the smallest (and necessarily negative) value of the parameter Rk1 .
Discussion. Note that the structure of the expression for R1 does resemble that one
for R0 and it can be interpreted as follows. First, following [28], we interpret the (i, j)
entry of V −1 as the average duration of time an individual introduced into the j-th
compartment spends in the i-th one, assuming there is no reinfection and no control.
The (i, i) entry of (−Wk) is the rate at which infected individuals are removed from the
i-th compartment, while the (i, j)-th component, i 6= j, corresponds to the rate at which
the infected from i-th compartment are moved to the j-th compartment. The respective
rates are multiplied by the control uk.
Hence, the (i, j)-th element of −WV −1 is the relative treatment-induced rate of flow
(outflow if negative or inflow if positive) from the i-th compartment as applied to the
individuals initially introduced into the j-th compartment. Note that
∑
i(−WV −1)i,j =
8
0 if the treatment consists in redistributing the infected individuals between infected
compartments and is negative if at least a part of infected individuals are removed to
the susceptible compartments as a result of treatment.
To interpret the right eigenvector of FV −1, corresponding to R0, recall that FV −1x0
is the expected number of new infections produced by the initial distribution of infected
individuals given by x0. Hence, the right eigenvector x0 can be interpreted as the worst
case distribution of the infected. In contrast to that, the left eigenvector y0 can be seen
as a worst case transmissibility rates, i.e., the transmissibility rates that result in the
maximal infection spread in the population taking into account the existing structure of
the transmission routes. Note that the eigenvectors are defined up to a positive factor
and hence should be seen as proportions rather than absolute values.
Finally, the expression −y>0 WV −1x0(y>0 x0)−1 can be interpreted as the total flow
of the infection due to the treatment computed for the worst case scenario. The term
(y>0 x0)
−1 serves as a normalizing factor. If the total flow is negative, the treatment
leads to a decrease in infection and to an increase otherwise. Note that R1 is negative if∑
i(−WV −1)i,j < 0 for all j.
Remark 3.1. There are two main advantages of considering R1, resp., R
k
1 in contrast
to working directly with R0(u) as defined in (8):
1. The function R0(u) depends on u in a highly nonlinear way, making it difficult if
ever possible to analyze the impact of the control on the controlled reproduction
number R0(u). In contrast, R1 is a well-defined quantity that does not depend on
u thus making it more amenable for analysis.
2. In general, the matrix (V +
∑m
k=1Wkuk)
−1
F has a complex structure which sub-
stantially complicates the problem of finding its spectral radius in an analytic form.
In contrast to that, Rk1 can be computed with much less effort. Also, we note that
the vectors x0 and y0 need to be computed only once. The modeler can then vary
the structure of Φu (and, respectively, Wk) to achieve the required effect in R
k
1 .
Remark 3.2. Note that the preceding results are formulated for sufficiently small values
of u. However, this assumption is not as restrictive as it may seem. The point is that each
component of the control u denotes a fraction of the set of potentially eligible individuals
that is enrolled into the respective treatment during a unit of time. In most practically
relevant cases, this fraction is rather small, ranging from thousandths to hundredths,
thus justifying the assumption.
3.3. Further extensions
The described method is substantially based upon the eigenvalue perturbation theory.
Namely, we analyze the behavior of the largest real eigenvalue (spectral radius) of a next
generation matrix under certain structured perturbations. All the presented results are
of local nature, i.e., these are valid for sufficiently small values of u. However, in many
cases it is possible to extend this analysis to larger values of u. Below, we consider several
possible scenarios and consider possible options and potential limitations.
The simplest case is when the rank of the matrix F is equal to 1. This corresponds to
the situation when all immediately infected individuals enter the same compartment, but
the infection itself can be caused by a contact with different types of infected. In this case,
there is only one non-zero positive eigenvalue coinciding with the spectral radius. The
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only possible limitation corresponding to this situation is that the controlled reproduction
number can change its behavior when the control u grows sufficiently large. One could
thus wish to study the behavior of R0(u) in some more detail. To do so one can compute
the second term in the series expansion which we denote by R2. The corresponding
expression is presented in Appendix A, Eq. (25). However, determination of R2 is a
rather cumbersome procedure involving computing Moore-Penrose pseudo inverse. On
the other hand, it seems that most cases the sign of R1 describes the behavior of R0(u)
for arbitrary large values of u and hence can be used for making global predictions.
When the rank of F is larger than 1, the matrix (V + uW )−1F has in general more
than one nonzero eigenvalue. A model of co-infection and two types of treatment, one
for each type of infection, is a typical example of such a situation. In this case, there
are two nonzero eigenvalues λ1(u1) and λ2(u2) controlled by the respective treatments
u1 and u2. Suppose that for u1 = u2 = 0, R0(0) = λ1(0) > λ2(0). Hence, the optimal
strategy (in terms of minimizing R0(u)) would be to invest into u1. However, as λ1(u1)
decreases, it will at some point equate with λ2(u2). Further investment into u1 will lead
to the change of the roles: λ2(u2) will become greater than λ1(u1) and hence will account
for R0(u).
In general, the behavior of the eigenvalues can be predicted by analyzing the structure
ofQ(u) = (V +uW )−1F . We assume here that this structure does not change with u, that
is, Qij(u) = 0, u > 0⇒ Qij(u) = 0,∀u > 0 and Qij(u) 6= 0, u > 0⇒ Qij(u) 6= 0,∀u > 0.
In this case there are two possible situations: the matrix Q(u) can be either irreducible or
reducible. The former implies that there is a simple real eigenvalue corresponding to the
spectral radius and hence to R0 (see, e.g., [24, Sec. 8.3]). If the matrix Q(u) is reducible,
one can find a permutation matrix P such that Q¯(u) = PQ(u)P−1 has a block-diagonal
form and the blocks on the main diagonal are irreducible. Since the eigenvalues of the
permuted matrix are determined by the diagonal blocks Q¯i(u) it suffices to track the
spectral radii of Q¯i(u); denote them by λ¯i(u). We have that R0(u) = maxi
(
λ¯i(u)
)
. If for
some u∗ it happens that λ¯i(u∗) = λ¯j(u∗) we have the situation described in the preceding
paragraph.
4. Examples
In this section we consider three sufficiently simple but yet non-trivial epidemiological
models that are aimed at illustrating the usefulness of the proposed approach.
4.1. An SI model with acute and chronic stages and a single treatment
Model. Consider an SI-model of a disease with two stages (acute and chronic) and a
treatment u. This general model structure with sequential infection compartments con-
taining infected persons with different levels of contagiousness describes the evolution
of such diseases as HIV [25] and syphilis [13] that have variable levels of contagiousness
over the course of infection. For the sake of illustration we explicitly show the ΦI , ΦC ,
10
and Φu components in (13).
d
dt

IA
IC
T
S
 =

α(X)S
0
0
0

︸ ︷︷ ︸
ΦI(x)
+

−βIA − µAIA
βIA + δT − µCIC
−δT − µTT
w − α(X)S − µSS

︸ ︷︷ ︸
ΦC(x)
+

0
−IC
IC
0

︸ ︷︷ ︸
Φu(x)
u (13)
where α(X) =
αAIA + αCIC + αTT
N
, X = [IA, IC , T, S], and N = IA + IC + T + S.
The states correspond to the number of acutely infected (IA), chronically infected (IC),
treated (T ), and susceptible (S) individuals. We assume that the first three compart-
ments are infectious with different transmission probabilities: αA, αC , and αT . Further-
more, β is the inverse duration of the acute phase, µS , µA, µC and µT are the mortality
rates for susceptible, non-treated in acute and chronic phases and treated infected, with
µC > {µA, µT } > µS , and δ is the rate at which the treatment fails.
Analysis. The disease-free equilibrium is unique and given by x∗ = [0, 0, 0, w/µS ]. The
(uncontrolled) value of R0 is computed as the spectral radius of FV
−1 and is equal to
R0 =
αCβ + αAµC
(β + µA)µC
Note that the DFE x∗ is unstable if αCβ + αAµC > (β + µS)µC . We wish to evaluate if
the proposed treatment strategy is efficient. To do so we compute R1 according to (9):
R1 = − β (αCµT − αTµC)
µ2C (β + µA) (δ + µT )
(14)
This expression is negative if αCµ > αTµC . This can be written as
αCµ
−1
C > αTµ
−1
T , (15)
that is the treatment turns out to be efficient if the product (transmission probability
times average residence time in the respective compartment) is lower for the treated in-
dividuals as compared with chronically infected. In the following, we will refer to this
product as the cumulative transmissibility of the infection induced by a given compart-
ment. The condition (15) can be interpreted as follows: If treated people live longer than
untreated (but infected), but their infectivity does not reduce enough to compensate for
this, such treatment will contribute to the propagation of the disease.
For the considered model it is possible to compute the controlled reproduction number
R0(u):
R0(u) =
(αCβ + αAµC) (δ + µT ) + (αTβ + αAµT )u
(β + µA)(δµC + µCµT + µTu)
.
One may check that R1 =
∂R0(u)
∂u
∣∣∣∣
u=0
. However, we are interested in the behavior of
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R0(u) for (relatively) large values of u. To do so, we compute the difference
R0(u)−R0 = − βu (αCµT − αTµC)
µC (β + µA) (δµC + µCµT + µTu)
. (16)
One can readily observe that the difference is negative for any u > 0 when (15) holds.
Figure 1 shows the relative error in the R1 approximation to R0(u) for a set of
random parameters as a function of R0. We obtained random parameter sets for a
given value of R0 optimizing from a random starting point for αA, αC , and β assuming
µA = µC = 120
−1, µT = 360−1, and αT = 0. We rejected parameter sets such that there
was no feasible control capable of reducing R0(u) to 1. The relative error is defined as
the difference in the exact value of u∗ such that R0(u∗) = 1 and u∗∗ = R0−1R1 normalized
by u∗. The approximate value of the control is always less than the true value and the
approximation becomes worse as the value of R0 increases, although the accuracy of the
approximation is dependent on the specific parameter values. However, if R0 is small the
approximation gives a reasonable indicator of the level of control required to bring the
epidemic to the threshold level.
0.25
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Figure 1: Relative error in approximate reduction in R0 due to treatment. This figure shows the
multiplicative-scale error defined as u
∗−u∗∗
u∗ where u
∗ such that R0(u∗) = 1 and u∗∗ = 1−R0R1 for a set
of randomly selected parameter values. Parameters with a given R0 between 1.1 and 4 were selected
at random as described in the text. The blue line is a local polynomial regression showing the general
trend.
4.2. An SEIR model with an asymptomatic stage and treatment
Model. Consider the model shown in Fig. 2. This model describes the transmission
dynamics of an asymptomatic (sub-clinical) infection. Individuals with asymptomatic
infection do not develop the respective symptoms, but are infectious and contribute to
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the distribution of the disease. Asymptomatic infection has been shown to exist for many
diseases, including, e.g., herpes [29], gonorrhea [20], measles [1], and common cold.
Figure 2: SEIR model.
Here, we have the following compartments: E – exposed, I – infected, A – asymp-
tomatically infected, T – treated. Λ is the inflow into the population, η is the transmission
rate, p1 is the probability that the exposition will lead to the typical clinical course and
p2 is the probability that the failed treatment will result in the typical clinical course.
Furthermore, x is the rate at which the treatment is failed or canceled, and γI , γA and γT
are the inverses of the mean residence time in respective compartments. We assume that
only the symptomatic infected, i.e., I, are treated. However, the disease can be transmit-
ted both by symptomatic and asymptomatic infected though with different transmission
rates αI and αA. People under treatment are assumed to be non-infectious.
Its behavior is described by the following DEs:
E˙ = α(X)S − (η + µ)E
A˙ = −(γA + µ)A+ η(1− p1)E + x(1− p2)T
I˙ = ηp1E − (γI + µ) I − uI + p2xT
T˙ = uI − (γT + µ+ x)T
S˙ = Λ− µS − α(X)S
R˙ = γAA+ γII + γTT − µR,
where α(X) =
αAA+ αII
N
.
Analysis. The basic reproduction number R0 is found using the NGM approach to be
R0 =
η
η + µ
[
αA
γA + µ
(1− p1) + αI
γI + µ
p1
]
,
where the expression in square brackets is the expected value of the total cumulative
transmissibility of the infection and the quantity in front of the brackets is the fraction
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of the infected that leave E toward either I or A.
We compute R1
R1 = −
ηp1
[
αI(γA + µ)(γT + µ) + (αI(γA + µ)− αA(γI + µ)) (1− p2)x
]
(η + µ) (γA + µ) (γI + µ)
2
(γT + µ+ x)
(17)
which turns out to be negative if the numerator is positive (note that the denominator
is always positive).
Upon some algebraic manipulations, this condition can be written as
αI
γI + µ
>
x(1− p2)
γT + µ
[
αA
γA + µ
− αI
γI + µ
]
. (18)
Define the cumulative transmissibilities of the A and I stages as ζA =
αA
γA+µ
and ζI =
αI
γI+µ
. With this, the condition (18) can be rewritten as
ζA − ζI
ζA
· x(1− p2) < γT + µ,
provided ζA > ζI (otherwise the condition (18) holds trivially as the r.h.s. of (18) turns
to be negative). The first term on the left side is the relative difference in cumulative
transmissibility and the second one is the flow from T to A. Finally, the expression
on the right side describes the flow from T to R or to outside the system. This result
underscores the importance of the treatment efficiency for the successful eradication of
the disease.
We proceed by considering the total change of R0 due to the control u
R0(u)−R0 =
− ηp1u [αI(γA + µ)(γT + µ) + (αI(γA + µ)− αA(γI + µ)) (1− p2)x]
(η + µ)(γA + µ)(γI + µ) [(γI + µ)(γT + µ+ x) + (γT + µ+ x(1− p2))u] . (19)
The denominator of (19) is always positive so, the condition for the treatment to be
efficient (that is the condition for the difference to be negative) is that the numerator is
positive. But the numerator of (19) coincides with the numerator of R1, (17), up to the
control u which is positive. Hence we conclude that satisfaction of the condition (18)
guarantees decrease in R0 for any positive value of u, i.e., gives a global condition.
4.3. An SI model with high- and low-risk groups and two treatments
Model. Consider a simplified model of HIV transmission dynamics with two controls
corresponding to treating infected individuals from the high- and the low-risk groups,
denoted by uT and uL. For the details on the derivation of the model see [18]. The
transmission dynamics is described by the following set of ODEs
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
I˙H = −IHµ− IHfLω + ILfHω + φH(X)SH − IHuH − µIIH
I˙L = −ILµ+ IHfLω − ILfHω + φL(X)SL − ILuL − µIIL
T˙H = TLfHω − THµ− THfLω + IHuH
T˙L = THfLω − TLµ− TLfHω + ILuL
S˙H = αH − SHµ− SHfLω + SLfHω − φH(X)SH
S˙L = αL − SLµ+ SHfLω − SLfHω − φL(X)SL,
(20)
where S{H,L}, I{H,L}, and T{H,L} are the susceptible, infected, and treated. The subscript
denotes the behavioral pattern of the respective group: there are a (H)igh and a (L)ow
risk group. Further, φH(X) = βλH
λHIH + λLIL
λHNH + λLNL
and φL(X) = βλL
λHIH + λLIL
λHNH + λLNL
are the per-capita transmission rates. µ is the mortality rate and µI is the disease-induced
mortality; ρH = fHω and ρL = (1− fH)ω = fLω are the transition rates between high-
and low-risk groups with ω denoting the volatility coefficient; λH and λL are the contact
rates; β is the infection transmissibility. Finally, the inflow rates are αH = fHµN and
αL = fLµN .
For the considered model, the disease free equilibrium is [I∗H , I
∗
L, T
∗
H , T
∗
L, S
∗
H , S
∗
L] =
[0, 0, 0, 0, fHN, fLN ]. Note that fH and fL are the fractions of the respective (high-
or low-risk) population at the DFE. Using the next generation matrix method we can
compute R0:
Analysis. The basic reproduction number is computed using the NGM method:
R0 =
β
(µI + µ+ ω)
CV (λ) +
β
(µI + µ)
[λ]
where [λ] = fLλL+fHλH and [λ
2] = λ2LfL+λ
2
HfH are the first and the second moments
of the contact rate at the DFE, Var(λ) is the variance of the contact rate, and CV is the
coefficient of variance defined as CV (λ) = Var(λ)
/
[λ]. Since there are two controls, we
would like to compare their contributions in order to decide which one should be invested
into. To compute the corresponding components RH1 and R
L
1 we use (12) to get
RH1 = −
βfH(λH(µI + µ) + [λ]ω)
2
(µI + µ)
2
[λ](µI + µ+ ω)
2
RL1 = −
βfL (λL(µI + µ) + [λ]ω)
2
(µI + µ)
2
[λ](µI + µ+ ω)
2
The first observation is that both RH1 and R
L
1 are negative thus, they contribute to
reducing R0(u) for any choice of parameters. After some algebraic manipulations we
find that uH is more efficient than uL if
fH
(
λH
[λ]
+
ω
µ
)2
> fL
(
λL
[λ]
+
ω
µ
)2
Figure 3 shows the value of λH such that the two terms in the inequality above are
equal. To account for the variability in the duration of the high and low-risk periods as
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a function of fH , we introduce the normalized volatility coefficient
ω∗ =
ωµ−1
fH
−1 + (1− fH)−1
,
which is the number of full high and low-risk episodes that can be contained in a typ-
ical infectious period. This plot shows that for fixed value of fH , behavioral volatility
makes high-risk intervention more plausible (i.e. the high-risk population does not have
to be extremely high-risk to make a targeted intervention efficient). This simple analysis
gives us a clear theoretical prescription for when to focus on high-risk group based on
measurable aspects of the transmission system.
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Figure 3: Minimum value of the high-risk contact rate, λH , for which the high-risk intervention is
preferred. The color shows the value of λH for which the terms in the above inequality are equal. For
any value of λH higher than the plotted value the high-risk intervention is preferred. The gray color
indicates that the value is either above 104 or there is no value such that the terms are equal. The
x-axis is the normalized volatility coefficient ω∗. The y-axis shows the fraction of the population that is
high-risk in the absence of disease. The remaining parameters are λL = 1 and µI = 0.
5. Discussion
The results presented in this paper can be applied to a wide class of epidemiological
models as long as their dynamics can be described by a compartmental system of form
(5). Our approach builds upon and further develops the next generation matrix method
in that it allows one to estimate the influence of the treatment-type control(s) on the basic
reproduction number R0 which defines the ultimate condition for eventual elimination of
a disease. The more a given control reduces R0, the closer the system is to elimination
and the more effective future interventions will be. Furthermore, it may turn out that
in complex models an intervention could unintentionally make things worse for certain
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populations. The basic premise of medicine to do no harm applies to public health as
well. However, the complex, non-linear dynamics of transmission limit the ability of
our intuitions to predict the effects of an intervention. Likewise, measurement of the
effects of interventions are often very noisy and can have long time lags. Both weak
measurability of outcomes and hard to predict dynamics highlight the need for stronger
theoretical guarantees that an intervention will not cause population-level harm. A
possible extension to this work could include consideration of complex models of how
risk behavior changes in response to changing prevalence and incidence of disease.
All our results are of local nature, i.e., these are valid for sufficiently small values of u.
However, in many cases it is possible to extend this analysis to larger values of u as was
illustrated by examples It should also be noted that the proposed approach does inherit
all the limitations associated with the NGM method. For instance, it provides only a
local stability condition and does not allow to make a conclusion about the behavior of
the system under large deviations.
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Appendix A. Proofs and computations
Proof of Lemma 3.1. One can readily observe that
∂Φui,k(x)
∂xj
= 0 for all j > l as Φui,k(x
∗)
turns to zero identically for any x∗ =
[
0l x
C
]>
. We thus consider the partial derivatives
of Φui,k(x
∗) w.r.t. xj for j = 1, . . . , l.
Let i, j ∈ {1, . . . , l}. We have
∂Φui,k(x)
∂xj
= lim
δxj→0
∑
q≤l
q 6=i
auiq,k(0, . . . , δxj , . . . , 0)−
∑
q 6=i
auqi,k(0, . . . , δxj , . . . , 0)
δxj
=

lim
δxj→0
−∑
q 6=i
auqi,k(0, . . . , δxj , . . . , 0)
δxj
≤ 0, i = j
lim
δxj→0
auij,k(0, . . . , δxj , . . . , 0)
δxj
≥ 0 i 6= j
For i ∈ {l + 1, . . . , n} and j ∈ {1, . . . , l}, the partial derivatives are
∂Φui,k(x)
∂xj
= lim
δxj→0
auij,k(0, . . . , δxj , . . . , 0)
δxj
≥ 0,
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which yields the required sign structure. Summation over j gives
∑n
j=1
∂Φui,k(x)
∂xj
= 0 for
all i = 1, . . . , l and hence, we have (note that the summation is performed only for j ≤ l)∣∣∣∣∂Φui,k(x)∂xj
∣∣∣∣ ≥∑
j≤l
j 6=i
∣∣∣∣∂Φui,k(x)∂xj
∣∣∣∣ . (21)
This implies that the matrix B11,k =
[
∂Φui,k(x)
∂xj
]
i=1,...,l
j=1,...,l
is weakly column diagonally
dominant as the inequality in (21) is not strict. 
Computation of the second order term in the expansion of R0(u). Let A(u) be a matrix
depending on u, r0 be the simple eigenvalue equal to the spectral radius of A(0), and
w0 and v0 be the left and the right eigenvectors corresponding to r0. We expand the
perturbed eigenvalue r(u) and the corresponding right eigenvector x(u) in a Taylor series
and keep the terms up to the second order: r(u) = r0 + r1u+ r2u
2 +O(u3) and x(u) =
v0 + v1u+ v2u
2 +O(u3). Thus we have
A(u)(v0 +v1u+v2u
2 +O(u3)) = (v0 +v1u+v2u
2 +O(u3))(r0 +r1u+r2u
2 +O(u3)) (22)
Differentiating (22) w.r.t. u and evaluating at u = 0 we get
(Ir0 −A(0))v1 = (A′(0)− Ir1)v0, (23)
whence the expression for r1 can be obtained: r1 = w
>
0 A
′(0)v0(w>0 v0)
−1 (cf. the proof
of Thm. 3.4). Substituting r1 back to (23) one gets an expression that can be used to
determine v1 (see [22, Chap. 8] for details):
v1 = (Ir0 −A(0))†
(
I − v0w
>
0
w>0 v0
)
A′(0)v0, (24)
where ()† is the Moor-Penrose inverse operator.
To compute the second term in the expansion of r(u) we differentiate (22) twice w.r.t.
u and evaluate at u = 0 to get
1
2
A′′(0)v0 +A′(0)v1 − v1r1 − v0r2 = (Ir0 −A(0))v2
Multiplying from the left by w>0 and substituting the previously obtained expressions for
r1 and v1 we arrive after some computations to the final expression for r2:
r2 =
(
w>0 v0
)−1
w>0
[
1
2
A′′(0) +A′(0)P0(Ir0 −A(0))†P0A′(0)
]
v0, (25)
where P0 = I − v0w
>
0
w>0 v0
is the oblique projection operator. Finally, we recall that A(u) =
(V + uW )−1F , whence A′(0) = V −1WV −1F and A′′(0) = −2V −2WV −2F .
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Appendix B. Special classes of matrices and their properties.
Definition 5.1. A matrix B ∈ Rn×n is non-negative, denoted by B  0, if bij ≥ 0 for
all i, j = 1, . . . , n.
Definition 5.2. A non-singular matrix A is said to be inverse positive if it satisfies
Rn≥0 ⊆ ARn≥0, which is equivalent to A−1  0, i.e., A−1Rn≥0 ⊆ Rn≥0.
Theorem 5.1. Let A = αI−B, where α > 0 and B  0. Then the following statements
are equivalent:
1. The matrix A is inverse positive,
2. The spectral radius of B is strictly smaller than α,
3. The matrix A is positive stable, i.e., if λ is an eigenvalue of A, then <(λ) > 0.
Definition 5.3. A matrix A = αI − B satisfying any of the properties of Thm. 5.1 is
said to be an M -matrix.
We will occasionally write M to denote the class of all n-by-n non-singular M -
matrices. The preceding results can be generalized in the following way. Let us define
the class of Z-matrices as Z = {A ∈ Rn×n|aij ≤ 0, i 6= j}. The following theorem gives a
number of conditions which guarantee that a given Z-matrix is a non-singular M-matrix.
For a complete list see [3].
Theorem 5.2. Let A ∈ Z. Any of the following conditions implies A ∈M.
1. A is inverse-positive.
2. A is positive stable.
3. A has all positive diagonal elements and is strictly row diagonally dominant (d.d.),
i.e.,
aii >
∑
i 6=j
|aij |, i = 1, . . . , n.
4. A has all positive diagonal elements and is strictly column d.d., i.e.,
aii >
∑
i 6=j
|aji|, i = 1, . . . , n.
Proof. We will prove only the last item as the remaining ones are covered in [3].
Let A ∈ Z and A be strictly column d.d., then A> ∈ Z and is strictly row d.d.
This implies A> ∈M. Since the spectrum of A coincides with that of A>, the positive
stability property holds for A and hence A ∈M.
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